Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Neurological Biomarkers

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1606348

This article is part of the Research TopicEmerging Trends in Moyamoya Disease: Diagnostic and Therapeutic InnovationsView all 7 articles

Alkaline Phosphatase Predicts Short-term Postoperative Outcome in Adult Patients with Moyamoya Disease

Provisionally accepted
Wei  SunWei Sun1Huihui  WangHuihui Wang2Qiheng  HeQiheng He1Junsheng  LiJunsheng Li1Chenglong  LiuChenglong Liu1Zhiyao  ZhengZhiyao Zheng1Siqi  MouSiqi Mou1Bojian  ZhangBojian Zhang1Zhikang  ZhaoZhikang Zhao1Chuming  TaoChuming Tao1Wei  LiuWei Liu1Xiangjun  ShiXiangjun Shi1Yan  ZhangYan Zhang1Peicong  GePeicong Ge1*Dong  ZhangDong Zhang3*Jun  WuJun Wu1*
  • 1Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 2Department of Hematology, Second Xiangya Hospital, Central South University, Changsha, Anhui Province, China
  • 3Beijing Hospital, Beijing, Beijing, China

The final, formatted version of the article will be published soon.

Background: Alkaline phosphatase (ALP) has played a pivotal role in vascular diseases in recent years. However, the association between ALP level and postoperative complications of moyamoya disease (MMD) has not been studied. Patients and Methods: Blood samples were collected from recruited patients with MMD. The serum ALP concentrations of the patients were determined using non-frozen specimens via an automated enzymatic assay. Patients were then divided into two groups according to the median, and a comparative analysis was performed. Patients were stratified into two cohorts for statistical evaluation based on the occurrence of postoperative stroke events. We employed a nomogram to identify risk factors for postoperative events. We also created a Cox model to analyze the risk factors for postoperative stroke events, including ALP. Furthermore, we plotted a restricted cubic spline (RCS) of ALP concentration versus postoperative stroke events. Results: We could find that the ALP concentration of non-postoperative stroke group and postoperative stroke group was 68.70 U/L and 71.15 U/L. This nomogram showed that ALP was a risk factor for postoperative events, and the Hosmer-Lemeshow goodness-of-fit test was employed, suggesting that the model was reliable (χ2 = 8.507, p = 0.386). And it also could obverse that there was a statistically positive correlation from the RCS between ALP concentration and postoperative stroke events Cox analysis (HR = 1.006, 95% CI = 1.002 – 1.010, p = 0.008). Conclusions: ALP levels may predict the short-term postoperative outcomes of MMD patients undergoing surgical treatment.

Keywords: Alkaline Phosphatase, Moyamoya Disease, biomarker, Outcome, postoperative

Received: 07 May 2025; Accepted: 08 Sep 2025.

Copyright: © 2025 Sun, Wang, He, Li, Liu, Zheng, Mou, Zhang, Zhao, Tao, Liu, Shi, Zhang, Ge, Zhang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Peicong Ge, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Dong Zhang, Beijing Hospital, Beijing, 100730, Beijing, China
Jun Wu, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.